Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer.

Chew HK, Doroshow JH, Frankel P, Margolin KA, Somlo G, Lenz HJ, Gordon M, Zhang W, Yang D, Russell C, Spicer D, Synold T, Bayer R, Hantel A, Stiff PJ, Tetef ML, Gandara DR, Albain KS.

J Clin Oncol. 2009 May 1;27(13):2163-9. doi: 10.1200/JCO.2008.17.4839. Epub 2009 Mar 23.

2.

A study of radiotherapy modalities combined with continuous 5-FU infusion for locally advanced gastrointestinal malignancies.

Shibata SI, Pezner R, Chu D, Doroshow JH, Chow WA, Leong LA, Margolin KA, McNamara MV, Morgan RJ Jr, Raschko JW, Somlo G, Tetef ML, Yen Y, Synold TW, Wagman L, Vora N, Carroll M, Lin S, Longmate J.

Eur J Surg Oncol. 2004 Aug;30(6):650-7.

PMID:
15256240
3.

Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96 h for the treatment of advanced malignancies.

Chow WA, Synold TW, Tetef ML, Longmate J, Frankel P, Lawrence J, Al-Khadimi Z, Leong L, Lim D, Margolin K, Morgan RJ Jr, Raschko J, Shibata S, Somlo G, Twardowski P, Yen Y, Doroshow JH.

Cancer Chemother Pharmacol. 2004 Sep;54(3):241-8. Epub 2004 Jun 2.

PMID:
15173955
4.

Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies.

Tetef ML, Synold TW, Chow W, Leong L, Margolin K, Morgan R, Raschko J, Shibata S, Somlo G, Yen Y, Groshen S, Johnson K, Lenz HJ, Gandara D, Doroshow JH.

Clin Cancer Res. 2001 Jun;7(6):1569-76.

5.

High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome.

Somlo G, Doroshow JH, Synold T, Longmate J, Reardon D, Chow W, Forman SJ, Leong LA, Margolin KA, Morgan RJ Jr, Raschko JW, Shibata SI, Tetef ML, Yen Y, Kogut N, Schriber J, Alvarnas J.

Br J Cancer. 2001 Jun 15;84(12):1591-8.

6.

A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine A.

Raschko JW, Synold TW, Chow W, Coluzzi P, Hamasaki V, Leong LA, Margolin KA, Morgan RJ, Shibata SI, Somlo G, Tetef ML, Yen Y, ter Veer A, Doroshow JH.

Cancer Chemother Pharmacol. 2000;46(5):403-10.

PMID:
11127945
7.

Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis.

Tetef ML, Margolin KA, Doroshow JH, Akman S, Leong LA, Morgan RJ Jr, Raschko JW, Slatkin N, Somlo G, Longmate JA, Carroll MI, Newman EM.

Cancer Chemother Pharmacol. 2000;46(1):19-26.

PMID:
10912573
8.

Supplemental Content

Loading ...
Support Center